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Introduction 
Chondrosarcoma is the second most 
common bone sarcoma, accounting for 
around 20% of bone sarcomas in the United 
States.1,2 It arises mainly in patients over 40 
years of age, has a slight male predominance 
and can be either primary or secondary to a 
previous benign chondral lesion such as an 
osteochondroma or an echondroma. 
Histologic grading, proposed by Linchtenstein 
and Jaffe is intended to reflect the 
aggressiveness of the lesion with grade 1 
tumors designated as low-grade and grades 
2 and 3 as high-grade neoplasms.1 
MHE (Multiple Hereditary Exostoses)is an 
autosomal dominant skeletal disorder 
characterized by the presence of multiple 
osteochondromas with a prevalence of 
approximately 1 in 50.000 individuals.3,4 MHE 
is synonymous with HME (Hereditary Multiple 
Exostoses), DiaphysealAclasia and Multiple 
Osteochondromas (MO).5,6,7The term 
“multiple exostoses” was given to the 
condition by Virchow in 1876.3Approximately 
15% of the osteochondroma patients have 
multiple lesions of which 62% have a positive 
family history.8The risk of malignant 
progression has been estimated between 1 to 
25% of patients with MHE.9,10 
Osteochondroma 
(osteocartilaginousexostosis) is a cartilage 
capped bony projection arising on the 
external surface of bone containing a marrow 
cavity that is continuous with that of the 
underlying bone.9,11,12Malignant 
transformation of Osteochondroma occurs 
mainly in the cartilaginous cap into low-grade 
chondrosarcomas. Low-grade 
chondrosarcomas tend to grow in the 
periphery, enlarging the cartilaginous cap, 
which produces the clinical alert signs and 
can be confirmed in MRI.13 
 
Etiology 
As with many cancers, the cause of 
chondrosarcoma is not clear. However, 
people with certain medical conditions have 
an increased risk for developing 
chondrosarcoma. These conditions include: 
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 Ollier’s Disease 
 Maffucci Syndrome 
 MHE (Multiple Hereditary Exostoses) 
 Wilm’s Tumor 
 Paget’s Disease 
 Diseases in children that required 
previous treatment with 
chemotherapy or radiation therapy.14 
Incidence 
Chondrosarcoma is a rare malignant tumor 
that produces cartilage matrix. The overall 
incidence of Chondrosarcoma is 1 in 200,000 
per year, and it is the third most frequent 
malignant bone tumor after Multiple Myeloma 
and Osteosarcoma.15,16 
Primary Chondrosarcoma typically affects an 
old population. The majority of patients are 
older than 50 years old. The peak incidence 
is in the fifth to seventh decades of life. There 
is a male predilection of 1,5-2 to 1.16Some of 
the newest literature suggest almost no 
gender differences in Chondrosarcoma.1,15 
Chondrosarcoma can involve any other bone; 
the incidence of axial and appendicular 
involvement is very similar. The bones of 
pelvis, especially for ilium are frequently 
involved. Long tubular bones are frequently 
affected. The proximal femur is the most 
preferred site, followed in frequency by 
proximal humerus, distal femur and ribs. 
Other less frequently involved bones are the 
spine, scapula and sternum. 
Chondrosarcoma rarely involves craniofacial 
bones, neck, forearm, clavicle and sesamoids 
(including the patella). Chondrosarcoma in 
the small tubular bones is extremely rare (1-
4% of all cases). 15,16 
Symptoms 
Clinical symptoms are mostly nonspecific. 
Localized pain is the most frequent 
presenting symptom (about 80%) after local 
swelling.14,16 The symptoms are usually 
insidious, progressive, worst at night and 
have a long duration (several months or 
years). Pathologic fractures are also common 
at initial presentation (up to 29%).2 Restricted 
range of motion (ROM) is a common report of 
individuals with severe involvement of the 
proximal femur and forearm. 3,7,12,14 
Signs 
 A mass that can be felt (palpable). 
 Broken bone (fracture).16 
Imaging 
Radiograph of conventional chondrosarcoma 
typically reveal a mixed lytic and sclerotic 
pattern with characteristic small calcifications, 
often referred as “popcorn”or 
“Ringlets”calcifications. Radiographic findings 
including cortical destruction, soft tissue 
extension and permeative pattern is often 
seen in high-grade tumors. Endosteal 
scalloping greater than two-third of the 
normal thickness of the long bones cortex is 
strong evidence of Chodrosarcoma over 
enchondroma.16 
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Magnetic Resonance Imaging (MRI) is a 
preferred modality in diagnosis of 
chondrosarcoma as well as in evaluation of 
the extent of marrow involvement and 
presence of soft tissue extension. 16 
Management 
Chondrosarcomas (CHS) represent a 
heterogeneous group of disorders ranging 
from indolent, low-grade tumors to aggressive 
high-grade tumors. Surgical resection 
represents the primary and preferred 
treatment modality for individuals with 
localized disease.1,14,16,17,18 Radiation therapy 
is appropriate for the treatment of positive 
surgical margins or palliation of disease 
related symptoms. The treatment of 
advanced, metastatic disease is particularly 
challenging given the recognition that 
conventional chemotherapy has proven to be 
largely ineffective.2,17 
Complication 
Great variation in biologic behavior between 
grades is characteristic of chondrosarcoma, 
ranging from a latent or slow-growing tumor 
to an aggressive sarcoma, with rapidly 
developing pulmonary metastasis. Low grade 
tumors usually have a more benign behavior, 
as well as a less aggressive aspect on 
imaging with no cortical expansion, 
destruction or soft tissue mass. High grade 
chondrosarcomas on the other hand typically 
exhibit all three.1 
 
Prognosis 
There is no consensus on prognostic factors 
to determine which patients have a higher 
risk of treatment failure and disease related 
death.2,14,15 The outcome of patients with 
primary central chondrosarcoma of bone who 
present with  localized disease is mostly 
affected by tumor.2,18Patients with Grade 1 
tumors have a 90% 5-year survival rate, 
whereas only 40% to 60% of patients with 
Grades 3 and 3 tumors will survive after 5 
years. A recent population study suggested 
that patients who survive for ten years are 
more likely to die of events that were 
unrelated to chondrosarcoma.1 
Case Report: 
A 26 years old woman came with a chief 
complain of the right hip had been 
uncomfortable since one year before. The 
uncomfortable feeling was worsened since 3 
months ago, and sometimes made her feel 
tingling in her right hip after activity. The 
range of movement was not disturbed. She 
had no history of trauma, and the family 
history was unremarkable. She had been 
operated because of swelling in the left radius 
and was diagnosed chondrofibroma in the left 
radius about 10 years ago. The swelling was 
not developed again after it had been 
operated. At presentation, a large, firm, and 
slightly tender mass was palpated near the 
right trochanter major. The tissue mass 
seemed to be attached to the bone.  Later 
she took CT scan for the uncomfortable 
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feeling in her right hip. The conclusion of the 
CT scan was osteochondroma. Later she 
took an open biopsy which was suggested by 
her orthopaedist, and again the result is 
osteochondroma. Because the lesion was 
highly suggestive of malignancy, the 
orthopaedist again recommend the patient to 
get a MRI for her bony mass. The result 
came with suspicion of high grade 
malignancy. She then assigned for a bone 
graft surgery, but during operation, the 
orthopaedist found out that the lump was so 
fragile, and was fractured during operation. 
Three weekslater, she was assigned again to 
get a total hip replacement surgery, which 
was continued by a 30 times of radiation. 
Now, the patient can have a quite normal 
daily activities although she cannot bend the 
right leg more than 90 degrees.
 
 
Picture 1. CT scan of pelvis (17/2/2015) 




Picture 2. MRI of the pelvis (17/2/2015) 




Picture 3. Pelvis AP after right total hip replacement (4/6/2015) 
Discussion: 
Chondrosarcoma is the second most 
common bone sarcoma, accounting for 
around 20% of bone sarcomas in the United 
States. It arises mainly in patients over 40 
years of age, has a slight male predominance 
and can be either primary or secondary to a 
previous benign chondral lesion such as an 
osteochondroma or an echondroma. 
Histologic grading, proposed by Linchtenstein 
and Jaffe is intended to reflect the 
aggressiveness of the lesion with grade 1 
tumors designated as low-grade and grades 
2 and 3 as high-grade neoplasms.    
Osteochondromais acartilage capped bony 
projection arising on the external surface of 
bone containing a marrow cavity that is 
continuous with that of the underlying bone. A 
diagnosis of MO can be made when 
radiologically at least two osteochondromas 
of the epiphyseal region of the long bones are 
observed, in which this patient we found 
nineexostoses on her right and left knee. She 
also have a positive family history of her older 
sister undergone a bone surgery.  
Usually in osteochondroma, we have a male 
predominance of 1.5 : 1, with more recent 
studies of nuclear families demonstrate no 
evidence of gender predominace, in this 
case, both of the patients are women, and 
their parents didn’t have previous history of 
abortion. History of any bone lumps of their 
parents is doubtful. Her older sister have a 
previous history of bone surgery, and with 
more careful investigations, we found that her 
older sister also have a MHE that  became 
chondrosarcoma on the right hip which was 
operated 1 year before, and also had a 
radiotherapy to cure the chondrosarcoma.  
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Clinical signs of malignant transformation 
include an increase in size of a lump and 
pain. The most important complication is 
malignant transformation of osteochondroma 
towards secondary peripheral 
chondrosarcoma, which is estimated to occur 
in 0,5 to 25%. The suspicion of secondary 
chondrosarcoma is indicated by growth of the 
tumor after puberty, the presence of pain, or 
a thickness over 1 cm of the cartilaginous cap 
in adults. That’s why we suggest the patient 
to seek for medical attention if her lumps are 
painful and increasing in size. 
Conclusion: 
This is a unique case of chondrosarcoma. 
From this case, we learn that, Multiple 
Hereditary Exostoses have strong connection 
with familial bond. This disease has male 
predominance, but in this case, the family 
don’t have any son, and the father are 
healthy without any sign and symptoms of 
lumps. As a physicians, it is important to take 
careful examinations if a patient complain of 
any bony lump, then it is necessary to take 
careful and thorough examination of the 
patient’s body, to know if there are other 
lumps in the patient’s body, because the 
chances of getting malignant transformations 
are bigger in patients who have multiple 
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